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Abstract 
Background: Sepsis is a life‑threatening organ dysfunction caused by a dysregulated host response to infection, 
being the primary cause of death from infection, especially if not recognized and treated promptly. The aim of this 
study was to analyze whether IL‑6 rs1800795 polymorphism is associated with septic shock‑related death in European 
white patients who underwent major surgery.
Methods: We performed a retrospective study on 202 septic shock patients who underwent major cardiac or 
abdominal surgery. The septic shock was established according to the international septic shock definition. The 
primary outcome variable was the death within 90 days after diagnosis of septic shock. The IL‑6 rs1800795 polymor‑
phism was genotyped by Sequenom’s MassARRAY platform.
Results: The median age of the patients was 73 years, 63.4% were male, and more than 40% of patients had heart 
disease and hypertension. Overall, the survival analysis showed that 111 (55%) patients died with a survival median 
of 39 days (95% CI 30.7; 47.2). The genetic analysis association with survival was performed under a recessive genetic 
model (CC vs. GG/CG). Patients with IL‑6 rs1800795 CC genotype had higher mortality rate than the IL‑6 rs1800795 
GG/CG genotype at days 7 [31.6% (6/19) vs. 10.4% (19/183); log‑rank test (p = 0.005)] and 28 [57.9% (11/19) vs. 
33.3% (61/183); log‑rank test (p = 0.009)], and 90 [68.4% (13/19) vs. 53.5% (98/183); log‑rank test (p = 0.006)]. The IL‑6 
rs1800795 CC genotype was associated with higher risk of septic shock‑related death during the first 7 days [adjusted 
hazard ratio (aHR 4.65; p = 0.002), 28 days (aHR 2.50; p = 0.006), and 90 days (aHR 2.28; p = 0.006)] with septic shock. 
When patients were stratified by type of surgery, those with IL‑6 rs1800795 CC genotype who underwent cardiac sur‑
gery had higher risk of death during the first 7 days (aHR 18.39; p = 0.001) and 28 days (aHR 6.1; p = 0.025) than IL‑6 
rs1800795 GG/GC carrier, whereas patients with IL‑6 rs1800795 CC genotype who underwent abdominal surgery had 
higher risk of death during all follow‑up (aHR 1.98; p = 0.050) than IL‑6 rs1800795 GG/GC carrier.
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Background
Sepsis is a life-threatening organ dysfunction caused 
by a dysregulated host response to infection, being the 
primary cause of death from infection, especially if it is 
from an unknown origin and it was not treated promptly 
[1]. Septic shock is a subset of sepsis in which underly-
ing circulatory and cellular/metabolic abnormalities 
are profound enough to substantially increase mortality 
[1]. Despite advances in treatment and supportive care 
in recent years, septic shock is a major healthcare prob-
lem, affecting millions of people around the world each 
year and killing a high percentage of patients in hospi-
tals [2], especially in intensive care unit (ICU) [2, 3]. In 
these patients, early and aggressive treatment has not 
improved survival [4], and patients that survive to sepsis 
remain at increased risk to death in the following months 
and years [5].
The immune dysfunction is the main pathophysiologi-
cal process in septic patients. These patients are severely 
immunocompromised and are unable to clarify invasive 
microbial pathogens [6], which may predict the survival 
of septic patients [7, 8]. Microbial antigens may cause 
the typical septic inflammatory cascade with overpro-
duction of proinflammatory cytokine (including TNF-α, 
IL-1, and IL-6), which may enter into the bloodstream 
causing hypercytokinemia [9]. These proinflammatory 
cytokines play an important role in the Janus kinase/
signal transducer and activator of transcription (JAK–
STAT) pathway, by transmitting their information into 
the cell nucleus for developing a specific response against 
microbial pathogens [9]. Moreover, proinflammatory 
cytokines may activate the suppressor of cytokine sign-
aling-3 (SOCS3) and may modulate the cytokine signal-
ing, usually preventing, but in some cases aggravating the 
outcome of infections [9].
The proinflammatory cytokines may also lead to 
endothelial damage and intravascular clotting, the for-
mation of blood clots in small blood vessels, multior-
gan failure, development of septic shock, and death [9, 
10]. Thus, plasma IL-6 levels have been associated with 
higher risk of sepsis, septic shock, and death [11–14]. 
However, it is not known clearly why under similar cir-
cumstances, some patients eliminate more easily an 
invading microorganism, whereas other patients develop 
sepsis and septic shock. In this regard, a variable to con-
sider is the host genetic factor, which has been related 
to sepsis outcome [15]. On this subject, the rs1800795 
single nucleotide polymorphism (SNP) at IL-6 promoter 
has been related to differential production of IL-6 [16]. 
Furthermore, the rs1800795 IL-6 polymorphism has 
been associated with the risk of sepsis and death, but 
with different results depending on the study [17–21]. 
Therefore, in patients who underwent major surgery, 
the role of the IL-6 rs1800795 SNP in septic shock is not 
clear yet.
The aim of this study was to analyze whether IL-6 
rs1800795 polymorphism is associated with septic shock-




We carried out a retrospective study on 202 European 
white patients older than 18 who developed septic shock. 
These patients underwent major cardiac or abdominal 
surgery at the Hospital Clínico Universitario of Valladolid 
(Spain) between April 2008 and November 2012. Major 
surgery was considered as an operative procedure in 
which the patient was under general anesthesia and res-
piratory assistance because the patient was not able to 
breathe independently.
The study was conducted in accordance with the Decla-
ration of Helsinki. All patients gave their written consent 
for the study. The Ethics Committee of Hospital Clínico 
Universitario (Valladolid) and Instituto de Salud Carlos 
III (Majadahonda) approved this study.
Control groups
We used a control group of 262 patients who only devel-
oped systemic inflammatory response syndrome (SIRS) 
[22] after major surgery (cardiac or abdominal) and had 
similar age and gender than septic shock patients. These 
patients were collected at the Hospital Clínico Universi-
tario between 2008 and 2012. Moreover, for healthy sub-
jects, the frequencies of alleles and genotypes for studied 
polymorphisms were obtained using the 1000 Genomes 
Project Web site (http://www.1000genomes.org/home), 
which provide a broad representation of common human 
genetic variation by applying whole-genome sequencing 
to a diverse set of individuals from multiple populations 
[23]. We select the Iberian populations in Spain (IBS) 
population that included 107 individuals.
Conclusions: The presence of IL‑6 rs1800795 CC genotype was associated with higher risk of septic shock‑related 
death in patients who underwent major cardiac or abdominal surgery. These findings need robust validation in big‑
ger independent cohorts.
Keywords: IL‑6, SNPs, Septic shock, Survival, Major surgery
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Clinical data
Demographic and clinical data were obtained from medi-
cal records: age, gender, type of surgery, prior or pre-
existing conditions such as diabetes, chronic obstructive 
pulmonary disease, hypertension, chronic kidney disease, 
cancer, liver disease and cardiomyopathy. Cardiopulmo-
nary bypass was carried out in all cardiac surgeries. Acute 
Physiology and Chronic Health Evaluation (APACHE-
II score) [24] and Sequential Organ Failure Assessment 
(SOFA score) [25] were calculated within the first 24  h 
after diagnosis, in order to evaluate severity of sepsis.
The diagnosis of septic shock was established according 
to the criteria laid down by the SCCM/ESICM/ACCP/
ATS/SIS International Sepsis Definitions Conference 
[22]. The presence of infection was either documented or 
presumed based on clinical findings. In those cases where 
infection was strongly suspected but not microbiologi-
cally confirmed, two experienced clinicians discussed 
and reached a consensus diagnosis according to physical 
and laboratory findings.
DNA genotyping
Total DNA was extracted from peripheral blood with 
High Pure PCR Template Preparation Kit (Roche Diag-
nostics GmbH, Mannheim, Germany). DNA samples 
were sent to the Spanish National Genotyping Center 
(CeGen; http://www.cegen.org/) for IL-6 rs1800795 poly-
morphism genotyping by using Sequenom’s MassARRAY 
platform (San Diego, CA, USA) and the iPLEX® Gold 
assay design system.
Outcome variable
The primary outcome variable was the death within 
90  days after diagnosis of septic shock. We used three 
points censoring: 7  days (very early mortality), 28  days 
(early mortality), and 90 days (late mortality).
Statistical analysis
For the description of the study population, p values were 
estimated with nonparametric tests: Mann–Whitney U 
test was used for continuous variable and Chi-squared/
Fisher’s exact test for categorical variables. For the 
genetic association study, the survival analysis (Kaplan–
Meier and Cox regression analyses) was used to compare 
the outcome variables according to the presence of IL-6 
rs1800795 CC genotype. Data were analyzed using domi-
nant, recessive and additive models, which were tested 
according to the goodness of fit evaluated by Akaike’s 
information criterion (AIC) value and Bayesian informa-
tion criterion (BIC).
Follow-up was censored at 90 days. Survival probabili-
ties were estimated using the Kaplan–Meier product-
limit method at 7, 28, and 90  days and compared using 
the log-rank test. Cox regression analyses were used to 
investigate the relationship of IL-6 rs1800795 polymor-
phism with the outcome variable during the first 7, 28, 
and 90 days. Each Cox regression test was adjusted by the 
most significant covariables for each outcome variable, 
avoiding the overfitting of the regression. The covari-
ables were selected by stepwise algorithm in a multivari-
ate model. We included the SNP [enter algorithm (forced 
entry for the SNP)] and the most relevant characteristics 
by stepwise algorithm (at each step, factors are consid-
ered for removal or entry: a p value for entry and exit of 
0.15 and 0.20, respectively). The covariables used were 
APACHE-II score, gender, age, antibiotic treatment, type 
of surgery (cardiac or abdominal), elective surgery (emer-
gency or scheduled), peritonitis, comorbidities [obesity, 
diabetes heart disease, chronic obstructive pulmonary 
disease (COPD)], hypertension, neoplasia, liver disease, 
smoker, and high alcohol intake. All statistical analyses 
were performed by using the IBM SPSS Statistics for 
Windows, version 21.0 (IBM Corp, Chicago, Armonk, 
NY, USA).
In addition, Hardy–Weinberg equilibrium (HWE) anal-
yses were computed by Haploview 4.2 software, consid-
ering equilibrium when p > 0.05.
Results
Characteristics of the study population
Table  1 shows demographic and clinical characteristics 
of shock septic patients at the time of septic shock diag-
nosis according to the IL-6 rs1800795 genotype. Overall, 
the median age was 73 years, 63.4% were male, and more 
than 40% of patients had heart disease and hypertension. 
Regarding the type of surgery, 40.1% were cardiac sur-
gery and 63.4% were emergency surgery. The most com-
monly isolated pathogens were gram-negatives (52.5%), 
and more than 40% of patients had peritonitis or pneu-
monia. When the population was stratified according to 
IL-6 rs1800795 genotype, we only found significant dif-
ferences in COPD frequencies (p = 0.027).
Additional file  1: Table S1 shows demographic and 
clinical characteristics of shock septic patients strati-
fied by the type of surgery (cardiac and abdominal). The 
cardiac surgery group had higher frequency of obesity 
(p = 0.045), heart disease (p < 0.001), and hypertension 
(p = 0.014) than the abdominal surgery group. Nonethe-
less, cardiac surgery group had lower frequency of can-
cer (p < 0.001) than the abdominal surgery group. Also, 
the cardiac surgery group had higher values of SOFA 
(p = 0.030) and APACHE (p = 0.032) than the abdomi-
nal surgery group. Regarding infection, the cardiac sur-
gery group had higher frequency of catheter bacteraemia 
(p  <  0.001), endocarditis (p  <  0.001), and pneumonia 
(p < 0.001) and lower frequency of peritonitis (p < 0.001).
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Characteristics of the IL‑6 polymorphism
Table  2 shows the frequencies of IL-6 rs1800795 poly-
morphism, which displayed missing values <5% and were 
in HWE (p > 0.05). The minor allele frequency was 32%. 
Data of our cohort were compared to the frequencies 
of IL-6 rs1800795 polymorphism in SIRS patients and 
healthy subjects from the IBS [23]. We did not find any 
significant difference.
Additional file 2: Table S2 shows the frequencies of IL-6 
rs1800795 polymorphism stratified according to the type 
of surgery. Overall, we found similar values of allelic and 
genotypic frequencies between cardiac and abdominal 
surgery compared to SIRS patients and reference popula-
tion (IBS); we did not find any significant difference with 
healthy subjects.
IL‑6 polymorphism and death in septic shock patients
We selected the recessive inheritance model (CC vs. GG/
CG) for the genetic association study, because it was the 
model that best fit to our data.
The survival probabilities at 7, 28, and 90  days after 
the diagnosis of septic shock are shown in Table 3. Out 
of 202 patients, 111 (55%) died with a survival median of 
39 days (95% CI 30.7; 47.2). Patients with IL-6 rs1800795 
Table 1 Summary of epidemiological and clinical characteristics of septic shock patients who underwent major surgery
Values are expressed as median (interquartile range) and absolute count (%)
Note that patients may have had more than one organism cultured
SOFA Sequential Organ Failure Assessment, APACHE Acute Physiology and Chronic Health Evaluation
* p values were calculated by Chi‑squared test or Fisher’s exact test for categorical variables and Mann–Whitney test for continuous variables. Statistically significant 
differences are shown in italics
Characteristics All patients IL‑6 rs1800795 polymorphism
GG/CG CC p value*
No. of patients 202 183 19 –
Gender (male) 128 (63.4%) 115 (62.8%) 13 (68.4%) 0.631
Age (years) 73 (17) 73 (17) 73 (17) 0.974
Prior or pre‑existing conditions
 Smoker 36 (17.8%) 35 (19.1%) 1 (5.3%) 0.207
 Alcoholism 15 (7.4%) 14 (7.7%) 1 (5.3%) 0.999
 Obesity 30 (14.9%) 27 (14.8%) 3 (15.8%) 0.999
 Diabetes 26 (12.9%) 23 (12.6%) 3 (15.8%) 0.718
 Heart disease 95 (45.5%) 82 (44.8%) 10 (52.6%) 0.515
 Chronic obstructive pulmonary disease 35 (17.3%) 28 (15.3%) 7 (36.8%) 0.027
 Hypertension 111 (50.0%) 100 (54.6%) 11 (57.9%) 0.789
 Chronic kidney disease 30 (14.9%) 28 (15.3%) 2 (10.5%) 0.745
 Cancer 47 (23.3%) 41 (22.4%) 6 (31.6%) 0.395
 Liver disease 9 (4.5%) 8 (4.4%) 1 (5.3%) 0.597
Surgery
 Cardiac (vs. abdominal) 81 (40.1%) 75 (41%) 6 (31.6%) 0.426
 Emergency (vs. scheduled) 128 (63.4%) 116 (63.4%) 12 (63.2%) 0.984
Severity indexes
 SOFA score 9 (4) 9 (4) 9 (3) 0.932
 APACHE‑II score 16 (5) 17 (5) 15 (8) 0.758
Infection
 Gram‑positive 99 (49%) 92 (50.3%) 7 (36.8%) 0.265
 Gram‑negative 106 (52.5%) 100 (54.6%) 6 (31.6%) 0.055
 Fungus 39 (19.3%) 35 (19.1%) 4 (21.1%) 0.767
 Catheter bacteraemia 68 (33.7%) 63 (34.4%) 5 (26.3%) 0.476
 Surgical site infection 48 (23.8%) 45 (24.6%) 3 (15.8%) 0.573
 Urinary tract infection 24 (11.9%) 21 (11.5%) 3 (15.8%) 0.479
 Endocarditis 10 (5%) 8 (4.4%) 2 (10.5%) 0.239
 Peritonitis 95 (47%) 86 (47%) 9 (47.4%) 0.975
 Pneumonia 95 (47%) 89 (48.6%) 6 (31.6%) 0.156
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CC genotype had lower survival probability than IL-
6 rs1800795 GG/CG genotype at 7  days (p  =  0.005), 
28 days (p = 0.009), and 90 days (p = 0.006).
 Table 4 shows the mortality risks at 7, 28, and 90 days 
for the IL-6 rs1800795 polymorphism by Cox regression 
analysis. The IL-6 rs1800795 CC genotype was associ-
ated with higher adjusted risk of septic shock-related 
death in the first 7 days [adjusted hazard ratio (aHR) 4.65; 
p =  0.002], 28  days (aHR 2.50; p =  0.006), and 90  days 
(aHR 2.28; p  =  0.006) than IL-6 rs1800795 GG/GC 
genotype.
 Additional file  3: Table S3 shows the mortality risks 
at 7, 28, and 90  days according to IL-6 rs1800795 poly-
morphism and stratified by type of surgery. The IL-6 
rs1800795 CC carrier who underwent cardiac surgery 
had higher risk of septic shock-related death during the 
first 7 days (aHR 18.39; p = 0.001) and 28 days (aHR 6.1; 
p = 0.025) than IL-6 rs1800795 GG/GC carrier, whereas 
IL-6 rs1800795 CC carrier who underwent abdominal 
surgery had higher risk of septic shock-related death dur-
ing all follow-up (90 days) (aHR 1.98; p = 0.050) than IL-
6 rs1800795 GG/GC carrier.
Discussion
To our knowledge, we described for the first time of the 
relationship between IL-6 rs1800795 polymorphism and 
risk of septic shock-related death in European patients 
who underwent major cardiac or abdominal surgery.
The genetic variation at cytokine genes may influence 
the risk of sepsis and death [15]. Among these genetic 
variations, the SNPs at IL-6 promoter are important 
members which might be associated with sepsis risk and 
death [17]. In our study, patients with IL-6 rs1800795 CC 
genotype had higher risk of septic shock-related death, 
suggesting that IL-6 rs1800795 polymorphism may play 
a major role in pathogenesis of septic shock. We ana-
lyzed allelic and genotypic frequencies of IL-6 rs1800795 
polymorphism between groups of patients: septic shock 
patients, SIRS patients, and healthy people (IBS). No 
significant differences were found, indicating that our 
cohort did not have any significant bias regarding the dis-
tribution of IL-6 polymorphism.
The IL-6 rs1800795 SNP has been previously associated 
with sepsis and death, but with discrepant results [17–
21]. In European population, the rs1800795 GG genotype 
was associated with protection against the development 
of septic shock in patients with pneumococcal commu-
nity-acquired pneumonia [17] and lower mortality [17, 
21]. In Greek population, the rs1800795 GG genotype did 
not show any association with severe sepsis and mortal-
ity [18]. In Asian population, the carriers of rs1800795 
C allele had higher risk of septic shock, but not higher 
risk of death [19]. In a recent meta-analysis, Gao et  al. 
[20] found a statistically significant association between 
rs1800795 CC genotype and sepsis-related mortality (CC 
vs. GC/GG: OR 1.92, p = 0.03), which disappeared after 
Bonferroni correction. In this regard, it should be taken 
into account that only six studies, four of them with lim-
ited sample size (n < 60), were included for meta-analysis 
Table 2 Frequencies of alleles and genotypes for IL-6 rs1800795 polymorphism in septic shock patients compared to Ibe-
rian populations in  Spain from  1000 Genomes Project data (http://www.1000genomes.org/1000-genomes-browsers) 
and SIRS patients
p values were calculated by Chi‑squared test: (a) differences between IBS population and septic shock patients, (b) differences between SIRS patients and septic shock 
patients
SIRS patients with systemic inflammatory response syndrome, IBS Iberian populations in Spain, HWE Hardy–Weinberg equilibrium, IL‑6 interleukin‑6
SNP IBS population SIRS patients Septic shock patients p valuea p valueb
N 107 263 202
HWE (p value) – 0.430 0.750
Alleles G 65% 63% 68% 0.684 0.306
C 35% 37% 32% – –
Genotypes GG 41.1% 40% 46% 0.481 0.229
GC 47.7% 44% 45% 0.730 0.903
CC 12.2% 15% 9% 0.490 0.071
Table 3 Survival probabilities at  7, 28, and  90  days 
(Kaplan–Meier product-limit method) for  IL-6 rs1800795 
polymorphism in  septic shock patients who underwent 
major cardiac or abdominal surgery













7 86.6 88.5 68.4 0.005
28 60.7 63.2 32.9 0.009
90 14.3 15.5 0.0 0.006
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about sepsis-related mortality. They concluded that 
current evidence does not support a direct effect of 
rs1800795 polymorphism on the risk of sepsis and more 
investigations would be needed to evaluate the effect of 
this polymorphism on sepsis mortality.
IL-6 is a proinflammatory cytokine which plays a vital 
role in the regulation of host immune response in sep-
sis, and elevated expression of IL-6 is associated with 
the development of severe sepsis and mortality [11–14]. 
This association may be mediated through a variable IL-6 
expression encoded by the host. The G to C polymor-
phism at position-174 of the IL-6 gene (rs1800795) causes 
differential activity in promoter constructs which up-reg-
ulates IL-6 gene transcription and promotes higher circu-
lating levels of IL-6 in individuals that carry rs1800795 G 
allele [16]. However, Tischendorf et al. observed a quan-
titative trait locus effect, IL-6 serum concentrations were 
highest in patients with the rs1800795 GG genotype, fol-
lowed by CG genotype, and lowest in individuals with CC 
genotype, but a high ex vivo secretion after LPS stimula-
tion in rs1800795 C carriers was found [26]. These dis-
crepancies among studies (including our study) might be 
due to the fact that rs1800795 polymorphism is not the 
causal mutation, or it is not uniquely responsible. Thus, it 
is possible that the effect rs1800795 SNP may also be due 
to other SNPs at IL-6 promoter, which are in high link-
age disequilibrium with rs1800795 polymorphism form-
ing a haplotype [27, 28]. In our study, plasma IL-6 values 
could be very helpful and convincing to reinforce the 
hypothesis that the observed effect of the IL-6 rs1800795 
polymorphism is a real biological result. However, IL-6 
measurements were not available in this study. As an 
alternative, a downstream biological measurement such 
as the white blood cell count, C reactive protein, and pro-
calcitonin was analyzed, but we did not find any signifi-
cant relationship of IL-6 rs1800795 polymorphism with 
these markers (data not shown).
We also performed an in silico analysis for evaluating 
the possible functional implication of rs1800795 poly-
morphism by using rSNABase (http://rsnp.psych.ac.cn/) 
[29]. This type of analysis allows to study whether the 
variant is located within regulatory regions and has a 
possible transcriptional regulatory effect. We found that 
IL-6 rs1800795 polymorphism, located within the pro-
moter of IL-6, could be part of RNA-binding protein site 
and could be involved in RNA-binding protein-mediated 
Table 4 Risk of death regarding IL-6 rs1800795 polymorphism in septic shock patients who underwent major cardiac or 
abdominal surgery
IL‑6 interleukin‑6, HR hazard ratio, aHR adjusted hazard ratio, 95% CI 95% confidence interval, p value level of significance
* p values were calculated by Cox regression adjusting for the most important clinical and epidemiological characteristics (see “Statistical analysis” section). Statistically 
significant differences are shown in italics (p < 0.05)
Univariate Multivariate
HR 95% CI p value aHR 95% CI p value*
The first 7 days
 rs1800795 CC 3.42 1.36; 8.85 0.009 4.6 1.8; 12.1 0.002
 Cardiac surgery 7.9 0.9; 71.1 0.064
 Obesity 2.4 0.9; 6.3 0.069
 Alcoholism 3.6 1.1; 11.1 0.028
 APACHE‑II score 1.1 1.1; 1.2 0.000
 Peritonitis 11.5 1.4; 97.4 0.025
The first 28 days
 rs1800795 CC 2.28 1.20; 4.34 0.012 2.5 1.3; 4.8 0.006
 Alcoholism 1.8 0.8; 3.7 0.135
 Emergency surgery 1.9 1.0; 3.6 0.050
 APACHE‑II score 1.0 1.0; 1.1 0.052
 Peritonitis 2.3 1.3; 3.9 0.003
 Heart disease 2.0 1.2; 3.4 0.005
The first 90 days
 rs1800795 CC 2.20 1.23; 3.96 0.008 2.3 1.3; 4.1 0.006
 Emergency surgery 1.8 1.2; 2.9 0.008
 Peritonitis 1.9 1.2; 2.9 0.005
 Heart disease 1.7 1.1; 2.6 0.010
 Liver disease 2.0 0.9; 4.7 0.107
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post-transcriptional regulation. Moreover, etiology and 
pathology of sepsis are complex, and the rs1800795 poly-
morphism may act synergistically with other genetic fac-
tors [15], which could be contributing to the risk of death 
in septic shock. These factors may be SNPs in different 
type of interleukins, which could play different roles in 
development of sepsis and clinical outcome [15].
In our study, the association between rs1800795 pol-
ymorphism and septic shock-related death was also 
found when the population was stratified by the type 
of surgery. However, patients with cardiac surgery 
showed a significant risk of septic shock-related death 
in the first 7 and 28 days, whereas patients who under-
went abdominal surgery had a significant risk during 
all follow-up (90 days). These different patterns may be 
intrinsic to each type of surgery, but we should not rule 
out the impact of the low sample size of surgery groups. 
Regarding the association found for cardiac surgery sub-
group, the extracorporeal circulation and the surgical 
injury itself produce complex inflammatory responses 
which can lead to varying degrees of ischemia–reperfu-
sion injury and/or systemic inflammatory response [30]. 
Under these circumstances, the role of IL-6 rs1800795 
polymorphism might be enhanced and this could jus-
tify the fact that we found a higher risk of death during 
the first 4  weeks of follow-up. Moreover, the associa-
tion found for abdominal surgery subgroup may be due 
to a faster development of sepsis than in patients who 
underwent cardiac surgery, because an intra-abdominal 
infection usually occurs in the first days of post-surgical 
intervention [4]. In this case, the influence of the IL-6 
rs1800795 polymorphism on the development of sep-
tic shock-related death seems to be maintained over 
time, but the effect is significant when the follow-up of 
patients reaches 90 days.
The attributable fatality rate of septic shock is high but 
has significantly dropped in last two decades due to the 
combination of anti-infective treatments and aggressive 
organ failure supports [4]. However, patients become 
exposed to ICU-acquired complications that significantly 
impact on their prognosis [31, 32]. In a recent article, 
Daviaud et al. [33] reported that early deaths are mainly 
attributable to intractable multiple organ failure related to 
the primary infection and late deaths are related to ICU-
acquired complications such as nosocomial infections 
and mesenteric ischemia. In our study, besides the IL-6 
rs1800795 polymorphism, we found a number of factors 
that were significantly associated with death. APACHE-
II score was the most relevant factor associated with the 
very early mortality, but this factor disappears in favor of 
others like emergency surgery, peritonitis, and heart dis-
ease in the late mortality. Moreover, we included in the 
analysis a high number of known prognostic factors, but 
we cannot exclude that other variables not recorded in 
our study could be influencing the clinical outcome.
Finally, several limitations should be taken into account 
for the correct interpretation of the results. Firstly, this 
report has a retrospective design and the sample size was 
relatively small, which could limit the achievement of 
statistically significant values between rs1800795 poly-
morphism and death, especially when we performed the 
analysis stratified by the type of surgery (abdominal or 
cardiac surgery). Besides, the limited sample size might 
increase the risk of false positive. However, we con-
trol homogeneity by only including patients with septic 
shock, without mixing different stages of disease. Sec-
ondly, differences in COPD were found when patients 
were stratified by rs1800795 genotype, but COPD was 
taken into account in the multivariate analysis. Thirdly, 
we used multiple points of censoring for death, which 
may cause problems of multiple comparisons. However, 
here is a considerable controversy about adjusting the “p 
value” after multiple tests on clinical-orientated studies 
[34, 35]. In our study, we had a hypothesis supported by 
theory and previous reports in septic patients. Therefore, 
we were not literally doing a random search of a mean-
ingful result, and our results should not be affected by the 
fact of carrying out a high number of statistical tests.
Conclusions
In conclusion, the presence of IL-6 rs1800795 CC geno-
type was associated with higher risk of septic shock-
related death in patients who underwent major cardiac or 
abdominal surgery. The IL-6 rs1800795 genotype could 
allow for a precision approach to the management of 
septic shock-related death risk. Further analysis involv-
ing large numbers of patients in independent cohorts is 
needed to corroborate these associations.
Abbreviations
IL‑6: interleukin‑6; JAK–STAT: Janus kinase/signal transducer and activator of 
transcription; SOCS3: suppressor of cytokine signaling‑3; SNP: single nucleo‑
tide polymorphism; SOFA: Sequential Organ Failure Assessment; APACHE: 
Acute Physiology and Chronic Health Evaluation; COPD: chronic obstructive 
pulmonary disease; HWE: Hardy–Weinberg equilibrium; IBS: Iberian popula‑
tions in Spain; aHR: adjusted hazard ratio.
Additional files
Additional file 1: Table S1. Summary of epidemiological and clinical 
characteristics of septic shock patients according to type of surgery.
Additional file 2: Table S2. Frequencies of alleles and genotypes for 
IL-6 rs1800795 polymorphism in septic shock patients compared to 
Iberian populations in Spain from 1000 Genomes Project data (http://
www.1000genomes.org/1000‑genomes‑browsers) and SIRS patients, 
according to type of surgery.
Additional file 3: Table S3. Adjusted risk of death regarding IL-6 
rs1800795 polymorphism in septic shock patients who underwent major 
cardiac or abdominal surgery.
Page 8 of 9Jiménez‑Sousa et al. Ann. Intensive Care  (2017) 7:22 
Authors’ contributions
ET and SR helped in funding body. MAJS, ET, and SR contributed to study con‑
cept and design. AO and RA collected the sample. ET, PL, MHR, EGP and EGS 
contributed to patients’ selection and clinical data acquisition. MAJS, LMM, 
and AFR helped in sample preparation, DNA isolation, and genotyping. MAJS 
and SR statistically analyzed and interpreted the data. MAJS and SR wrote 
the manuscript. LMM, AFR, ET critically revised the manuscript for important 
intellectual content. SR supervised the study. All authors read and approved 
the final manuscript.
Author details
1 Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, 
Instituto de Salud Carlos III (Campus Majadahonda), Carretera Majadahonda‑ 
Pozuelo, Km 2.2, 28220 Majadahonda, Madrid, Spain. 2 Departamento de 
Anestesiología y Reanimación, Hospital Clínico Universitario, Valladolid, Spain. 
3 Unidad de Investigación Médica en Infección e Inmunidad, Hospital Clínico 
Universitario‑IECSCYL, Valladolid, Spain. 
Acknowledgements
The authors wish to thank the Spanish National Genotyping Center (CeGen) 
for providing the genotyping services (http://www.cegen.org). We also 
acknowledge the patients in this study for their participation.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The datasets were analyzed during the current study available from the cor‑
responding author on reasonable request.
Ethics approval and consent to participate
The study was approved by the Research Ethic Committee of the Instituto 
de Salud Carlos III and was conducted in accordance with the Declaration of 
Helsinki. All patients gave their written informed consent.
Funding
This work has been supported by grants given by Instituto de Salud Carlos III 
(Grant Numbers PI15/01451 to ET), “Gerencia de Salud, Consejería de Sanidad, 
Junta de Castilla y Leon” (Grant No. GRS 463/A/10 and 773/A/13 to ET), and 
PFIZER (Grant No. CT25‑ESP01‑01 to SR). MAJS, LMM, and AFR are supported 
by “Instituto de Salud Carlos III” (Grant Nos.: CD13/00013, CD14/00002, and 
CP14CIII/00010, respectively).
Received: 22 July 2016   Accepted: 18 February 2017
References
 1. Titmarsh CJ, Moscovis SM, Hall S, Tzanakaki G, Kesanopoulos K, Xirogianni 
A, et al. Comparison of cytokine gene polymorphisms among Greek 
patients with invasive meningococcal disease or viral meningitis. J Med 
Microbiol. 2013;62(Pt 5):694–700. doi:10.1099/jmm.0.058073‑0.
 2. Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two 
decades of mortality trends among patients with severe sepsis: a com‑
parative meta‑analysis. Crit Care Med. 2014;42(3):625–31. doi:10.1097/
CCM.0000000000000026.
 3. Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. 
Outcomes of the surviving sepsis campaign in intensive care units in 
the USA and Europe: a prospective cohort study. Lancet Infect Dis. 
2012;12(12):919–24. doi:10.1016/S1473‑3099(12)70239‑6.
 4. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. 
Surviving sepsis campaign: international guidelines for management of 
severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–
228. doi:10.1007/s00134‑012‑2769‑8.
 5. Endler G, Marculescu R, Starkl P, Binder A, Geishofer G, Muller M, et al. 
Polymorphisms in the interleukin‑1 gene cluster in children and young 
adults with systemic meningococcemia. Clin Chem. 2006;52(3):511–4. 
doi:10.1373/clinchem.2005.058537.
 6. Machado JR, Soave DF, da Silva MV, de Menezes LB, Etchebehere RM, 
Monteiro ML, et al. Neonatal sepsis and inflammatory mediators. Mediat 
Inflamm. 2014;2014:269681. doi:10.1155/2014/269681.
 7. Shao R, Li CS, Fang Y, Zhao L, Hang C. Low B and T lymphocyte attenuator 
expression on CD4+ T cells in the early stage of sepsis is associated with 
the severity and mortality of septic patients: a prospective cohort study. 
Crit Care. 2015;19:308. doi:10.1186/s13054‑015‑1024‑4.
 8. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 
2010;38(2 Suppl.):S26–34. doi:10.1097/CCM.0b013e3181c98d21.
 9. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, et al. 
Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 
1beta production in Helicobacter pylori infection. Gastroenterology. 
2002;123(6):1793–803. doi:10.1053/gast.2002.37043.
 10. Deutschman CS, Tracey KJ. Sepsis: current dogma and new perspectives. 
Immunity. 2014;40(4):463–75. doi:10.1016/j.immuni.2014.04.001.
 11. Hack CE, De Groot ER, Felt‑Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, 
Eerenberg‑Belmer AJ, et al. Increased plasma levels of interleukin‑6 in 
sepsis. Blood. 1989;74(5):1704–10.
 12. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex 
pattern of cytokines in serum from patients with meningococcal septic 
shock. Association between interleukin 6, interleukin 1, and fatal out‑
come. J Exp Med. 1989;169(1):333–8.
 13. Tschaikowsky K, Hedwig‑Geissing M, Braun GG, Radespiel‑Troeger M. 
Predictive value of procalcitonin, interleukin‑6, and C‑reactive protein 
for survival in postoperative patients with severe sepsis. J Crit Care. 
2011;26(1):54–64. doi:10.1016/j.jcrc.2010.04.011.
 14. Andaluz‑Ojeda D, Bobillo F, Iglesias V, Almansa R, Rico L, Gandia F, et al. 
A combined score of pro‑ and anti‑inflammatory interleukins improves 
mortality prediction in severe sepsis. Cytokine. 2012;57(3):332–6. 
doi:10.1016/j.cyto.2011.12.002.
 15. Christaki E, Giamarellos‑Bourboulis EJ. The beginning of personal‑
ized medicine in sepsis: small steps to a bright future. Clin Genet. 
2014;86(1):56–61. doi:10.1111/cge.12368.
 16. Fishman D, Faulds G, Jeffery R, Mohamed‑Ali V, Yudkin JS, Humphries S, 
et al. The effect of novel polymorphisms in the interleukin‑6 (IL‑6) gene 
on IL‑6 transcription and plasma IL‑6 levels, and an association with sys‑
temic‑onset juvenile chronic arthritis. J Clin Investig. 1998;102(7):1369–76. 
doi:10.1172/JCI2629.
 17. Martin‑Loeches I, Sole‑Violan J, Rodriguez de Castro F, Garcia‑Laorden MI, 
Borderias L, Blanquer J, et al. Variants at the promoter of the interleu‑
kin‑6 gene are associated with severity and outcome of pneumococcal 
community‑acquired pneumonia. Intensive Care Med. 2012;38(2):256–62. 
doi:10.1007/s00134‑011‑2406‑y.
 18. Panayides A, Ioakeimidou A, Karamouzos V, Antonakos N, Koutelidakis 
I, Giannikopoulos G, et al. 572 G/C single nucleotide polymorphism 
of interleukin‑6 and sepsis predisposition in chronic renal disease. 
Eur J Clin Microbiol Infect Dis. 2015;34(12):2439–46. doi:10.1007/
s10096‑015‑2500‑0.
 19. Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, et al. Year 
in review in intensive care medicine 2011. II. Cardiovascular, infections, 
pneumonia and sepsis, critical care organization and outcome, educa‑
tion, ultrasonography, metabolism and coagulation. Intensive Care Med. 
2012;38(3):345–58. doi:10.1007/s00134‑012‑2467‑6.
 20. Gao JW, Zhang AQ, Pan W, Yue CL, Zeng L, Gu W, et al. Association 
between IL‑6‑174G/C polymorphism and the risk of sepsis and mortality: 
a systematic review and meta‑analysis. PLoS ONE. 2015;10(3):e0118843. 
doi:10.1371/journal.pone.0118843.
 21. Gupta DL, Nagar PK, Kamal VK, Bhoi S, Rao DN. Clinical relevance of single 
nucleotide polymorphisms within the 13 cytokine genes in North Indian 
trauma hemorrhagic shock patients. Scand J trauma Resusc Emerg Med. 
2015;23:96. doi:10.1186/s13049‑015‑0174‑3.
 22. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 
2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions 
conference. Crit Care Med. 2003;31(4):1250–6. doi:10.1097/01.
CCM.0000050454.01978.3B.
 23. Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, et al. A 
global reference for human genetic variation. Nature. 2015;526(7571):68–
74. doi:10.1038/nature15393.
 24. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of 
disease classification system. Crit Care Med. 1985;13(10):818–29.
Page 9 of 9Jiménez‑Sousa et al. Ann. Intensive Care  (2017) 7:22 
 25. Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, et al. 
The use of maximum SOFA score to quantify organ dysfunction/failure 
in intensive care. Results of a prospective, multicentre study. Working 
group on sepsis related problems of the ESICM. Intensive Care Med. 
1999;25(7):686–96.
 26. Wojtowicz A, Gresnigt MS, Lecompte T, Bibert S, Manuel O, Joosten 
LA, et al. IL1B and DEFB1 polymorphisms increase susceptibility to 
invasive mold infection after solid‑organ transplantation. J Infect Dis. 
2015;211(10):1646–57. doi:10.1093/infdis/jiu636.
 27. Garcia‑Ramirez RA, Ramirez‑Venegas A, Quintana‑Carrillo R, Camarena AE, 
Falfan‑Valencia R, Mejia‑Arangure JM. TNF, IL6, and IL1B polymorphisms 
are associated with severe influenza A (H1N1) virus infection in the Mexi‑
can population. PLoS ONE. 2015;10(12):e0144832. doi:10.1371/journal.
pone.0144832.
 28. Zhang AQ, Pan W, Gao JW, Yue CL, Zeng L, Gu W, et al. Associations 
between interleukin‑1 gene polymorphisms and sepsis risk: a meta‑
analysis. BMC Med Genet. 2014;15:8. doi:10.1186/1471‑2350‑15‑8.
 29. Wen AQ, Wang J, Feng K, Zhu PF, Wang ZG, Jiang JX. Effects of haplo‑
types in the interleukin 1beta promoter on lipopolysaccharide‑induced 
interleukin 1beta expression. Shock. 2006;26(1):25–30. doi:10.1097/01.
shk.0000223125.56888.c7.
 30. Wen AQ, Gu W, Wang J, Feng K, Qin L, Ying C, et al. Clinical relevance 
of IL‑1beta promoter polymorphisms (−1470, −511, and −31) in 
patients with major trauma. Shock. 2010;33(6):576–82. doi:10.1097/
SHK.0b013e3181cc0a8e.
 31. Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoreg‑
ulators and potential therapeutic targets—an updated view. Mediat 
Inflamm. 2013;2013:165974. doi:10.1155/2013/165974.
 32. Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, 
et al. Interleukin‑1 receptor blockade is associated with reduced mortality 
in sepsis patients with features of macrophage activation syndrome: 
reanalysis of a prior phase III trial. Crit Care Med. 2016;44(2):275–81. 
doi:10.1097/CCM.0000000000001402.
 33. Daviaud F, Grimaldi D, Dechartres A, Charpentier J, Geri G, Marin N, 
et al. Timing and causes of death in septic shock. Ann Intensive Care. 
2015;5(1):16.
 34. Perneger TV. What’s wrong with Bonferroni adjustments. BMJ. 
1998;316(7139):1236–8.
 35. Sterne JA, Davey SmithG. Sifting the evidence—what’s wrong with 
significance tests? BMJ. 2001;322(7280):226–31.
